No Data
No Data
Express News | Anixa Biosciences Inc - Vaccine Currently Being Studied in Phase One Clinical Trial at Cleveland Clinic
Express News | Anixa Biosciences Collaborator, Cleveland Clinic Receives Decision To Grant Notice From Japan Patent Office For Patent Titled 'Vaccine Adjuvants and Formulations.'
Express News | Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Express News | Anixa Biosciences Announces $5 Million Share Repurchase Program
Express News | EXCLUSIVE: Anixa Biosciences Tells Benzinga Co's Board Of Directors Has Authorized A Share Repurchase Program Up To $5 Million Of The Co's Common Stock
Express News | Anixa Biosciences Treats Sixth Patient In Ongoing Phase 1 Clinical Trial Of Chimeric Antigen Receptor T-Cell Therapy For Ovarian Cancer
TrytosaveabitOP : HOTSHOT369!!!!! Thank you for catching that! Was doing to much and didn’t notice! I owe you one!